Role of angiogenesis in the development and growth of liver metastasis

Annals of Surgical Oncology

Volumn 9, Issue 7, 2002, Pages 610-616

  Takeda, Akihiko ^a   Stoeltzing, Oliver ^a   Ahmad, Syed A ^a   Reinmuth, Niels ^a   Liu, Wenbiao ^a   Parikh, Alexander ^a   Fan, Fan ^a   Akagi, Morihisa ^a   Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Angiogenic factors; Liver metastasis; Microenvironment

Indexed keywords

INTERLEUKIN 8; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; CANCER GROWTH; CANCER INVASION; CELL SURVIVAL; COLORECTAL CARCINOMA; ENDOTHELIUM CELL; HUMAN; LIVER METASTASIS; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

ENDOTHELIAL GROWTH FACTORS; HUMANS; INTEGRINS; INTERLEUKIN-8; LIVER; LIVER NEOPLASMS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE PHOSPHORYLASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036340808     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2002.9.7.610     Document Type: Review

References (48)

1. What is the evidence that tumors are angiogenesis dependent?
2. The implications of angiogenesis for the biology and therapy of cancer metastasis
3. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture
4. Tumor angiogenesis: The role of oncogenes and tumor suppressor genes
5. Growth dominance of the metastatic cancer cell: Cellular and molecular aspects
6. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
7. Modulation of the organ microenvironment for treatment of cancer metastasis
8. Role of the tumor microenvironment in mediating response to anti-angiogenic therapy
9. Molecular determinants in the biology of liver metastasis
10. An immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissue
11. Histologic growth patterns of metastatic carcinomas of the liver
12. Morphological aspects of angiogenesis in experimental liver metastases
13. Angiogenesis of liver metastases: Role of sinusoidal endothelial cells
14. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis
15. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
16. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer
17. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
18. Angiogenin expression in human colorectal cancer: The role of focal macrophage infiltration
19. Expression of angiomodulin (tumor-derived adhesion factor/mac 25) in invading tumor cells correlates with poor prognosis in human colorectal cancer
20. Interleukin 10 expression is correlated with thrombospondin expression and decreased vascular involvement in colon cancer
21. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: Role of infiltrating cells
22. Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer
23. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers
24. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma
25. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer
26. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
27. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer
28. Interleukin-8 and MCAF: Novel leukocyte recruitment and activating cytokines
29. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic
30. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials
31. Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis
32. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas
33. Separate functions of alpha2betal and alpha3betal integrins in the metastatic process of human gastric carcinoma
34. Involvement of integrin alphavbeta3 in cell adhesion, motility, and liver metastasis of murine RAW117 large cell lymphoma
35. Reduction of colon cancer growth by a novel antiangiogenic agent that targets the integrin 51
36. The (v)-(3) inhibitor S247 decreases colon cancer metastasis, angiogenesis and improves survival in a murine model of liver metastasis
37. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
38. Thymidine phosphorylase is angiogenic and promotes tumor growth
39. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma
40. Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer
41. Suppression of metastasis by thymidine phosphorylase inhibitor
42. Isolation and properties of a thrombin-sensitive protein of human platelets
43. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines
44. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer
45. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis
46. Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis
47. Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms
48. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases